Vir Biotechnology appoints Aziz Sawaf as CFO
Vir Biotechnology named Aziz Sawaf as EVP and CFO, replacing the outgoing officer. With 20 years of biopharma experience, Sawaf is expected to strengthen financial oversight and capital allocation as Vir advances its oncology and hepatitis delta programs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed